Discontinuation report HEPTOVIR

Last updated on 2022-08-05 History
Report ID 160500
Drug Identification Number 02239193
Brand name HEPTOVIR
Common or Proper name lamivudine tablets
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) LAMIVUDINE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size All pack sizes / Tous les formats
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-08-12
Actual discontinuation date
Remaining supply date 2023-01-05
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-08-05 French Compare
v11 2022-08-05 English Compare
v10 2022-07-29 French Compare
v9 2022-07-29 English Compare
v8 2022-07-22 French Compare
v7 2022-07-22 English Compare
v6 2022-07-15 French Compare
v5 2022-07-15 English Compare
v4 2022-07-06 French Compare
v3 2022-07-06 English Compare
v2 2022-05-13 French Compare
v1 2022-05-13 English Compare

Showing 1 to 12 of 12